Directory
>
Rick Morgan
Rick Morgan
Interim Chief | Be Biopharma
Massachusetts, Cambridge, United States
Rick Morgan
Summary
Dr. Rick Morgan is a distinguished Chief Scientific Officer at Be Biopharma, where he is pioneering novel therapies using engineered B cells. With a robust background in immunotherapy and gene editing, he previously held senior roles at Editas Medicine and bluebird bio, where he made significant contributions to cancer treatment advancements. Dr. Morgan's career began at the NIH, where he led groundbreaking research in gene therapy for genetic disorders and infectious diseases. He has authored over 190 scientific publications, collaborating with Nobel laureates, showcasing his deep commitment to advancing medical science. His leadership extends to serving on the board of the American Society of Gene and Cell Therapy. Dr. Morgan holds degrees in Biochemistry and Genetics from Brandeis University and Johns Hopkins University, respectively, positioning him as a thought leader in biotechnology. Beyond his impressive credentials, he is passionate about translating scientific innovation into real-world therapies that improve patient outcomes.
Rick Morgan
Work Experience
Chief Scientific Officer at
Be Biopharma
March 2021 - Present
Rick Morgan
Education
Johns Hopkins University, Doctor of Philosophy (PhD), Genetics
January 1981 - January 1987
Brandeis University, Bachelor of Arts (BA), Biochemistry
January 1977 - January 1981
Frequently Asked Questions about Rick Morgan
What is Rick Morgan email address?
Rick Morgan's primary email address is *******@be.bio. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Rick Morgan work for?
Rick Morgan is a Interim Chief at Be Biopharma.
Where Rick Morgan graduated from?
Rick Morgan holds a degree in null from Johns Hopkins University.
How can I directly contact Rick Morgan?
To contact Rick Morgan directly, you can use the email address *******@be.bio. Complete contact information is available upon registration with Muraena.
Who is Rick Morgan?
Dr. Rick Morgan is a distinguished Chief Scientific Officer at Be Biopharma, where he is pioneering novel therapies using engineered B cells. With a robust background in immunotherapy and gene editing, he previously held senior roles at Editas Medicine and bluebird bio, where he made significant contributions to cancer treatment advancements. Dr. Morgan's career began at the NIH, where he led groundbreaking research in gene therapy for genetic disorders and infectious diseases. He has authored over 190 scientific publications, collaborating with Nobel laureates, showcasing his deep commitment to advancing medical science. His leadership extends to serving on the board of the American Society of Gene and Cell Therapy. Dr. Morgan holds degrees in Biochemistry and Genetics from Brandeis University and Johns Hopkins University, respectively, positioning him as a thought leader in biotechnology. Beyond his impressive credentials, he is passionate about translating scientific innovation into real-world therapies that improve patient outcomes.
Rick`s contact details
*******@be.bio
Colleagues
Project Manager/Sr CRA
Staff Scientist